The Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder in Patients with Epilepsy
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Attention deficit/hyperactivity disorder (AD/HD) can cause significant impairment in psychosocial and scholastic achievement. AD/HD should be appropriately managed even if patients have comorbid epilepsy. The diagnosis and treatment of AD/HD in patients with epilepsy presents several challenges. Differentiating independent problems in attention from frequent epileptic seizures is the first step in evaluating these individuals. Once this is accomplished the formal independent diagnosis of AD/HD can be pursued. Data from non-epileptic AD/HD populations should be applied with caution to patients with epilepsy. Once attention deficit disorder has been diagnosed formally, choices in treatment can create other problems as some pharmacological treatments for AD/HD pose a risk of exacerbating seizures. This article serves as a review for the diagnosis and treatment of AD/HD spectrum disorders in patients with epilepsy.
- Fisher RS, Boas WE, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470–2. CrossRef
- • Feldman H, Crumrine P, Handen L, et al. MPH in children with seizures and Attention-Deficit Disorder. AJDC. 1989;143:1081–6. This double blind placebo controlled crossover trial is notable because it showed that treatment with methylphenidate improved the teachers Conner’s rating scale in 70 % of patients with well treated epilepsy. There was no increase in seizure frequency in the patient population, but the study was inadequately powered to answer the question of a change in seizure freedom.
- •• Gonzalez-Heydrich J, Whitney J, Waber D, et al. Adaptive phase I study of OROS MPH treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010;18:229–37. This is 1 of 2 double blind controlled placebo controlled cross over trials evaluating the use of methylphenidate treatment in patients with AD/HD and epilepsy. There was up to a 75% response to treatment compared with a 6% response with placebo. This study was underpowered to appropriately assess a change in seizure frequency. CrossRef
- •• Koneski JAS, Casella EB, Agertt F, Ferreira MG. Efficacy and safety of MPH in treating AD/HD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review. Epilepsy Behav. 2011;21:228–32. Unlike the previous studies, this study evaluated the efficacy of methylphenidate on patients with AD/HD and poorly controlled epilepsy. Eight percent of patients experienced worsening in seizure frequency which was statistically significant. CrossRef
- Swanson JM, Sandman CA, Deutsch C, et al. MPH hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects. Pediatrics. 1983;72:49–55.
- • Gross-Tsur V, Manor O, Van Der Meere J, et al. Epilepsy and attention-deficit hyperactivity disorder: is MPH safe and effective? J Pediatr. 1997;130:40–4. This study is important in that it revealed which patients were likely to have worsened seizure control on treatment for AD/HD. CrossRef
- Thomas S, Upadhyaya H. Adderall and seizures. J Am Acad Child Adolesc Psychiatry. 2002;41:365. CrossRef
- Feijoo M, Bilbao J. Seizures of sleep onset: clinical and therapeutical aspects. Clin Neuropharmacol. 1992;15:50–5. CrossRef
- Hernandez AJC, Barragan PEJ. Efficacy of atomoxetine treatment in children with AD/HD and epilepsy. Epilepsia. 2005;46:241.
- Torres A, Whitney J, Rao S, et al. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Epilepsy Behav. 2011;20:95–102. CrossRef
- Zhang D, Li F, Zhu X, et al. Clinical observations on Attention-Deficit Hyperactivity Disorder (AD/HD) in children with frontal lobe Epilepsy. J Child Neurol. 2012;00:1–4.
- Tovia E, Goldberg-Stern H, Zeev BB, et al. The prevalence of atypical presentations and comorbidities of benign childhood epilepsy with centrotemporal spikes. Epilepsia. 2011;52:1483–8. CrossRef
- •• Hemmer SA, Pasternak JF, Zecker SG, Trommer BL. Stimulant therapy and seizure risk in children with AD/HD. Pediatr Neurol. 2001;24:99–102. This study is important in that, to date it is the largest retrospective study of healthy children treated with methylphenidate with the goal of analyzing seizure outcome. 10% of children with epileptiform discharges on electroencephalogram went on to have seizures whereas 0.6% of the patients without epileptiform discharges went on to have seizures. Seizures only occurred in the treatment group. CrossRef
- Schneebaum-Sender N, Goldberg-Stern H, Frattal-Valevski A, et al. Does a normalizing electroencephalogram in benign childhood epilepsy with centrotemporal spikes abort attention deficit hyperactivity disorder? Pediatr Neurol. 2012;47:279–83. CrossRef
- Wroblewski BA, Leary JM, Phelan AM, et al. MPH and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry. 1992;53:86–9.
- Finck S, Metz-Lutz MN, Becache E, et al. Attention-Deficit Hyperactivity Disorder in epileptic children: a new indication for MPH? Ann Neurol. 1995;38:22–59.
- Semrud-Clikeman M, Wical B. Components of attention in children with complex partial seizures with and without AD/HD. Epilepsia. 1999;40:1999. CrossRef
- Moore JL, McAuley JW, Long L, Bornstein R. An evaluation of the effects of MPH on outcomes in adult epilepsy patients. Epilepsy Behav. 2002;3:92–5. CrossRef
- Gucuyener K, Erdemoglu AK, Senol S, et al. Use of MPH for Attention-Deficit Hyperactivity Disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol. 2003;18:109–12. CrossRef
- Van der Feltz-Cornelis CM, Aldenkamp AP. Corrigendum to “Effectiveness and safety of MPH in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial”. [Epilepsy Behav 2006;8:659–62]. Epilepsy Behav. 2006;9:542. CrossRef
- McBride MC, Wang DD, Torres CF. MPH in therapeutic doses does not lower seizure threshold. Ann Neurol. 1986;20:43–60.
- The Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder in Patients with Epilepsy
Current Neurology and Neuroscience Reports
- Online Date
- May 2013
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Attention deficit hyperactivity disorder
- Industry Sectors
- Author Affiliations
- 1. Penn Epilepsy Center, University of Pennsylvania, Philadelphia, PA, USA
- 2. Department of Neurology, Medical College of Wisconsin, 9200 W. Wisconsin Ave, Milwaukee, Wi, 53226, USA
- 3. Comprehensive Epilepsy Center, Froedtert Hospital, Milwaukee, Wi, USA